239 related articles for article (PubMed ID: 28007765)
61. Transient acquisition of pluripotency during somatic cell transdifferentiation with iPSC reprogramming factors.
Maza I; Caspi I; Zviran A; Chomsky E; Rais Y; Viukov S; Geula S; Buenrostro JD; Weinberger L; Krupalnik V; Hanna S; Zerbib M; Dutton JR; Greenleaf WJ; Massarwa R; Novershtern N; Hanna JH
Nat Biotechnol; 2015 Jul; 33(7):769-74. PubMed ID: 26098448
[TBL] [Abstract][Full Text] [Related]
62. Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog.
Moon JH; Yun W; Kim J; Hyeon S; Kang PJ; Park G; Kim A; Oh S; Whang KY; Kim DW; Yoon BS; You S
Biochem Biophys Res Commun; 2013 Feb; 431(3):444-9. PubMed ID: 23333380
[TBL] [Abstract][Full Text] [Related]
63. Human Ocular Epithelial Cells Endogenously Expressing SOX2 and OCT4 Yield High Efficiency of Pluripotency Reprogramming.
Poon MW; He J; Fang X; Zhang Z; Wang W; Wang J; Qiu F; Tse HF; Li W; Liu Z; Lian Q
PLoS One; 2015; 10(7):e0131288. PubMed ID: 26131692
[TBL] [Abstract][Full Text] [Related]
64. Concise review: Oct4 and more: the reprogramming expressway.
Sterneckert J; Höing S; Schöler HR
Stem Cells; 2012 Jan; 30(1):15-21. PubMed ID: 22009686
[TBL] [Abstract][Full Text] [Related]
65. Nuclear reprogramming with a non-integrating human RNA virus.
Driscoll CB; Tonne JM; El Khatib M; Cattaneo R; Ikeda Y; Devaux P
Stem Cell Res Ther; 2015 Mar; 6(1):48. PubMed ID: 25889591
[TBL] [Abstract][Full Text] [Related]
66. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells.
Masui S; Nakatake Y; Toyooka Y; Shimosato D; Yagi R; Takahashi K; Okochi H; Okuda A; Matoba R; Sharov AA; Ko MS; Niwa H
Nat Cell Biol; 2007 Jun; 9(6):625-35. PubMed ID: 17515932
[TBL] [Abstract][Full Text] [Related]
67. OCT4 activity during conversion of human intermediately reprogrammed stem cells to iPSCs through mesenchymal-epithelial transition.
Teshigawara R; Hirano K; Nagata S; Ainscough J; Tada T
Development; 2016 Jan; 143(1):15-23. PubMed ID: 26657769
[TBL] [Abstract][Full Text] [Related]
68. Characterization of two POU transcription factor family members from the urochordate Oikopleura dioica.
Cupit PM; Lennard ML; Hikima J; Warr GW; Cunningham C
Gene; 2006 Nov; 383():1-11. PubMed ID: 16989962
[TBL] [Abstract][Full Text] [Related]
69. Transcriptome Signature and Regulation in Human Somatic Cell Reprogramming.
Tanaka Y; Hysolli E; Su J; Xiang Y; Kim KY; Zhong M; Li Y; Heydari K; Euskirchen G; Snyder MP; Pan X; Weissman SM; Park IH
Stem Cell Reports; 2015 Jun; 4(6):1125-39. PubMed ID: 26004630
[TBL] [Abstract][Full Text] [Related]
70. Epigenetic Aberrations Are Not Specific to Transcription Factor-Mediated Reprogramming.
Tiemann U; Wu G; Marthaler AG; Schöler HR; Tapia N
Stem Cell Reports; 2016 Jan; 6(1):35-43. PubMed ID: 26711876
[TBL] [Abstract][Full Text] [Related]
71. Pharmacological Reprogramming of Somatic Cells for Regenerative Medicine.
Xie M; Tang S; Li K; Ding S
Acc Chem Res; 2017 May; 50(5):1202-1211. PubMed ID: 28453285
[TBL] [Abstract][Full Text] [Related]
72. Expression level of pluripotent genes in incomplete reprogramming.
Zhao X; Li Q; Jiang WM; Liu HY; Ma N; Zhou Z; Li LJ; Huang YH; Ma YL
Asian Pac J Trop Med; 2014 Aug; 7(8):639-644. PubMed ID: 25149378
[TBL] [Abstract][Full Text] [Related]
73. Efficient Generation of Non-Integration and Feeder-Free Induced Pluripotent Stem Cells from Human Peripheral Blood Cells by Sendai Virus.
Ye H; Wang Q
Cell Physiol Biochem; 2018; 50(4):1318-1331. PubMed ID: 30355953
[TBL] [Abstract][Full Text] [Related]
74. O-GlcNAc regulates pluripotency and reprogramming by directly acting on core components of the pluripotency network.
Jang H; Kim TW; Yoon S; Choi SY; Kang TW; Kim SY; Kwon YW; Cho EJ; Youn HD
Cell Stem Cell; 2012 Jul; 11(1):62-74. PubMed ID: 22608532
[TBL] [Abstract][Full Text] [Related]
75. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
76.
Yang XC; Wu XL; Li WH; Wu XJ; Shen QY; Li YX; Peng S; Hua JL
Zool Res; 2022 Nov; 43(6):911-922. PubMed ID: 36052561
[TBL] [Abstract][Full Text] [Related]
77. Reversal of Xenopus Oct25 function by disruption of the POU domain structure.
Cao Y; Oswald F; Wacker SA; Bundschu K; Knöchel W
J Biol Chem; 2010 Mar; 285(11):8408-21. PubMed ID: 20064932
[TBL] [Abstract][Full Text] [Related]
78. Transcriptional protein-protein cooperativity in POU/HMG/DNA complexes revealed by normal mode analysis.
Wang DD; Yan H
Comput Math Methods Med; 2013; 2013():854710. PubMed ID: 24324527
[TBL] [Abstract][Full Text] [Related]
79. Crystallization and preliminary X-ray analysis of human Brn-5 transcription factor in complex with DNA.
Pereira JH; Ha SC; Kim SH
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Mar; 64(Pt 3):175-8. PubMed ID: 18323601
[TBL] [Abstract][Full Text] [Related]
80. Diversity, phylogeny and expression patterns of Pou and Six homeodomain transcription factors in hydrozoan jellyfish Craspedacusta sowerbyi.
Hroudova M; Vojta P; Strnad H; Krejcik Z; Ridl J; Paces J; Vlcek C; Paces V
PLoS One; 2012; 7(4):e36420. PubMed ID: 22558464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
